Schedule 13G ownership disclosure

Epizyme, Inc.

Security class unavailable · CUSIP: 29428V104

Event date: 2017-03-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,699,675
Percent of class
8.0700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001306923-17-000017
Form type
SC 13G
Filer
Epizyme, Inc.
CIK
CIK 1571498
Filed
Apr 03, 2017
Reporting period
Mar 23, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub